Pharma Plus, S.A. De C.V., a prominent player in the pharmaceutical industry, is headquartered in Mexico (MX) and operates extensively across various regions in the country. Founded in 2005, the company has established itself as a trusted provider of high-quality healthcare products and services, focusing on prescription medications, over-the-counter drugs, and health supplements. With a commitment to innovation and customer care, Pharma Plus distinguishes itself through its rigorous quality control processes and a diverse product portfolio tailored to meet the needs of healthcare professionals and patients alike. The company has achieved significant milestones, including strategic partnerships and a growing market presence, solidifying its position as a leader in the Mexican pharmaceutical landscape.
How does Pharma Plus, S.A. De C.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pharma Plus, S.A. De C.V.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Plus, S.A. De C.V., headquartered in Mexico, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Pharma Plus may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Pharma Plus to consider setting measurable climate goals and participating in industry-standard initiatives to enhance their environmental responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharma Plus, S.A. De C.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.